<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03258164</url>
  </required_header>
  <id_info>
    <org_study_id>H-16046960</org_study_id>
    <nct_id>NCT03258164</nct_id>
  </id_info>
  <brief_title>Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts</brief_title>
  <official_title>Fat Transplantation Enriched With Expanded Adipose-derived Autologous Mesenchymal Stromal Cells in Cosmetic Breast Augmentation and Cosmetic Facial Filling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stemform</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aleris-Hamlet Hospitaler København</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stemform</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study is to examine whether enrichment of a fat graft with&#xD;
      autologous ex vivo expanded ASC injected into the breast tissue or face, both for cosmetic&#xD;
      use, will significantly improve the results of conventional lipofilling and synthetic facial&#xD;
      fillers, thereby being able to offer a safer, more natural and long-lasting alternative to&#xD;
      current artificial solutions for cosmetic patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The cosmetic breast augmentation design is a double-blind (surgeon and data assessor)&#xD;
      randomized, prospective clinical study on healthy subjects.&#xD;
&#xD;
      The cosmetic facial filling design is a data assessor-blinded, randomized, prospective&#xD;
      clinical study on healthy subjects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">March 22, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in volume over time after breast augmentation</measure>
    <time_frame>Baseline, four and twelve months</time_frame>
    <description>Measurement of the residual volume of fat transplants as based on MRI before operation (baseline), and four and twelve months after lipo-injection to the breast in order to determine the difference in volume between baseline and 4 months and 12 months post operative; and thereby the resorption rate over time.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cosmetic facial appearance over time after facial filling</measure>
    <time_frame>Baseline, one, four and twelve months</time_frame>
    <description>Assessment of cosmetic outcome based on clinical photos before (baseline), one, four and twelve months after the procedure when compared to baseline, evaluated by 5 independent plastic surgeons blinded to the intervention using a scale of 1-5 to determine the difference in appearance over time.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Breast Hypoplasia and Facial Ageing</condition>
  <arm_group>
    <arm_group_label>ASC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ASC enriched lipofilling</intervention_name>
    <description>Fat grafts enriched with ex vivo expanded ASC</description>
    <arm_group_label>ASC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Standard Lipofilling</intervention_name>
    <description>Non-ASC enriched fat grafts</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Criteria breast augmentation:&#xD;
&#xD;
        Inclusion criteria&#xD;
&#xD;
          1. Age 18 - 50 years&#xD;
&#xD;
          2. Healthy females&#xD;
&#xD;
          3. BMI 18 - 30 kg/m2&#xD;
&#xD;
          4. 1000 ml of fat (lipoaspirate) available for liposuction at the abdomen and/or thighs&#xD;
&#xD;
          5. Desire for breast augmentation&#xD;
&#xD;
          6. Speaks and reads Danish or English&#xD;
&#xD;
          7. Signed informed consent&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          1. Smoking&#xD;
&#xD;
          2. Previous breast surgery&#xD;
&#xD;
          3. Previous cancer or predisposition to breast cancer&#xD;
&#xD;
          4. Pregnancy or planned pregnancy within one year after the procedure&#xD;
&#xD;
          5. Breastfeeding less than 6 months prior to inclusion&#xD;
&#xD;
          6. Weight gain or loss above 2 BMI point&#xD;
&#xD;
          7. Known chronic disease associated with metabolism malfunction or pour healing&#xD;
&#xD;
          8. Pacemaker or other implanted foreign objects&#xD;
&#xD;
          9. Allergy towards necessary anaesthesia&#xD;
&#xD;
         10. Intention of weight loss or weight gain within the trial period&#xD;
&#xD;
        Criteria fascial filling&#xD;
&#xD;
        Inclusion criteria&#xD;
&#xD;
          1. Age 25 - 65 years&#xD;
&#xD;
          2. Healthy females&#xD;
&#xD;
          3. BMI 18 - 30 kg/m2&#xD;
&#xD;
          4. 100 ml of fat (lipoaspirate) available for liposuction at the abdomen and/or thighs&#xD;
&#xD;
          5. Desire for facial wrinkle treatment and facial augmentation (rejuvenation)&#xD;
&#xD;
          6. Speaks and reads Danish or English&#xD;
&#xD;
          7. Signed informed consent&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          1. Smoking&#xD;
&#xD;
          2. Previous facial surgery&#xD;
&#xD;
          3. Previous cancer&#xD;
&#xD;
          4. Pregnancy or planned pregnancy within one year after the procedure&#xD;
&#xD;
          5. Known chronic disease associated with metabolism malfunction or poor healing&#xD;
&#xD;
          6. Allergy towards necessary anaesthesia&#xD;
&#xD;
          7. Intention of weight loss or weight gain within the trial period&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stig-Frederik T Kølle, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stemform</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stemform</name>
      <address>
        <city>Copenhagen</city>
        <state>Søborg</state>
        <zip>2860</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 7, 2017</study_first_submitted>
  <study_first_submitted_qc>August 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2017</study_first_posted>
  <last_update_submitted>June 21, 2019</last_update_submitted>
  <last_update_submitted_qc>June 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Results will be published in international medical journals</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

